NCT07132515View on ClinicalTrials.gov

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
CirrhosisHCC - Hepatocellular CarcinomaPortal Vein Thrombosis
Interventions
DRUG

Enoxaparin, warfarrin, or apixaban

Enoxaparin, warfarrin, or apixaban

Trial Locations (1)

35511

RECRUITING

Mansoura University Hospitals, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER